Seikagaku Corporation
Seikagaku Corporation, a leading biopharmaceutical company based in Japan, has established itself as a key player in the field of regenerative medicine and orthopaedics since its founding in 1947. With its headquarters in Tokyo, Seikagaku operates extensively across Asia, Europe, and North America, focusing on the development and manufacturing of innovative products that enhance joint health and tissue regeneration. The company is renowned for its core offerings, including hyaluronic acid-based products, which are uniquely designed to treat osteoarthritis and promote joint function. Seikagaku's commitment to research and development has positioned it as a pioneer in the industry, achieving significant milestones such as the introduction of groundbreaking therapies that have transformed patient care. With a strong market presence and a dedication to advancing medical science, Seikagaku Corporation continues to lead the way in biopharmaceutical innovation.
DitchCarbon Score
How does Seikagaku Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Seikagaku Corporation's score of 40 is higher than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Seikagaku Corporation's reported carbon emissions
In 2024, Seikagaku Corporation reported total carbon emissions of approximately 21,000,000 kg CO2e, comprising about 8,345,000 kg CO2e from Scope 1 and about 13,023,000 kg CO2e from Scope 2. In 2023, the company’s emissions in Japan were about 22,721,000 kg CO2e for Scope 1 and 2 combined, with an additional 57,262,000 kg CO2e attributed to Scope 3 emissions globally. Seikagaku has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or any formal climate pledges. However, the company continues to monitor and report its emissions, indicating a commitment to transparency in its sustainability efforts. The absence of Scope 3 emissions data in some reports suggests a potential area for future focus as the company seeks to enhance its climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 8,441,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,945,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Seikagaku Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
